Abstract
In West Africa, the bushmeat trade is a major societal issue with contrasting implications on biodiversity, health and economy. We studied perceptions of the impact of the COVID-19 pandemic on the bushmeat trade dynamics through questionnaires addressed to 377 vendors across three West African countries. We showed that bushmeat vendors constitute a socio-economic category driven by ethnicity and gender bias, engaged in profitable, long-term careers. There was a general consensus among vendors that the COVID-19 pandemic and related governmental measures had a negative impact on their activities and the number of clients, a cost still perceived as visible at the time of the survey. However, we observed large discrepancies among the national trade dynamics relative to the constraints of the pandemic. Côte d’Ivoire was hardly hit by the bushmeat ban and perceived governmental measures as rather negative, whereas Cameroon generally did not report a temporary stop of bushmeat activities and engaged in the stockpiling of pangolins, and Benin mostly suffered from a weakened supply chain. Because such differences are rooted in the geography and political agenda of each country, predicting the impact of mitigation measures on the global dynamics of bushmeat markets might be an unrealistic task if national specificities are not taken into account. West African vendors generally did not believe that pangolins were involved in the pandemic, for the reason that people have always been eating pangolins and have never been sick. We recommend that future awareness campaigns through television and social networks also include education on microbial evolution and host shift.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study was funded ANRS MIE, the Second Contract of Debt Reduction Development Contracts (C2Ds), the National Research Foundation (South Africa), AMRUGE CI 2, FCT IC&DT 02/SAICT/2017/032130, and IRD / Department ECOBIO.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
In Cote d Ivoire, ethical clearance was provided by the Comite National d Ethique des Sciences de la Vie et de la Sante under clearance 007-21/MSHP/CNESVS-km In Benin, the Comite d Ethique de l Universite d Abomey Calavi delivered clearance 4613-2020/UAC/SG/SA. In Cameroon, ethical clearance 2510 CEI-UDo/03/2021/P was attributed by the Comite d Ethique Institutionnel de la Recherche pour la Sante Humaine de l Universite de Douala.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
